Literature DB >> 11532944

The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif.

C Schaeffer1, B Bardoni, J L Mandel, B Ehresmann, C Ehresmann, H Moine.   

Abstract

Fragile X syndrome is caused by the absence of protein FMRP, the function of which is still poorly understood. Previous studies have suggested that FMRP may be involved in various aspects of mRNA metabolism, including transport, stability and/or translatability. FMRP was shown to interact with a subset of brain mRNAs as well as with its own mRNA; however, no specific RNA-binding site could be identified precisely. Here, we report the identification and characterization of a specific and high affinity binding site for FMRP in the RGG-coding region of its own mRNA. This site contains a purine quartet motif that is essential for FMRP binding and can be substituted by a heterologous quartet-forming motif. The specific binding of FMRP to its target site was confirmed further in a reticulocyte lysate through its ability to repress translation of a reporter gene harboring the RNA target site in the 5'-untranslated region. Our data address interesting questions concerning the role of FMRP in the post-transcriptional control of its own gene and possibly other target genes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11532944      PMCID: PMC125594          DOI: 10.1093/emboj/20.17.4803

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  60 in total

1.  Dihydrofolate reductase protein inhibits its own translation by binding to dihydrofolate reductase mRNA sequences within the coding region.

Authors:  E A Ercikan-Abali; D Banerjee; M C Waltham; N Skacel; K W Scotto; J R Bertino
Journal:  Biochemistry       Date:  1997-10-07       Impact factor: 3.162

2.  Participation of the human p53 3'UTR in translational repression and activation following gamma-irradiation.

Authors:  L Fu; S Benchimol
Journal:  EMBO J       Date:  1997-07-01       Impact factor: 11.598

3.  General RNA binding proteins render translation cap dependent.

Authors:  Y V Svitkin; L P Ovchinnikov; G Dreyfuss; N Sonenberg
Journal:  EMBO J       Date:  1996-12-16       Impact factor: 11.598

4.  Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits.

Authors:  T A Comery; J B Harris; P J Willems; B A Oostra; S A Irwin; I J Weiler; W T Greenough
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

5.  Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation.

Authors:  I J Weiler; S A Irwin; A Y Klintsova; C M Spencer; A D Brazelton; K Miyashiro; T A Comery; B Patel; J Eberwine; W T Greenough
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

Review 6.  hnRNP proteins and the biogenesis of mRNA.

Authors:  G Dreyfuss; M J Matunis; S Piñol-Roma; C G Burd
Journal:  Annu Rev Biochem       Date:  1993       Impact factor: 23.643

7.  The fragile X mental retardation protein is associated with poly(A)+ mRNA in actively translating polyribosomes.

Authors:  F Corbin; M Bouillon; A Fortin; S Morin; F Rousseau; E W Khandjian
Journal:  Hum Mol Genet       Date:  1997-09       Impact factor: 6.150

8.  Modulation of AUUUA response element binding by heterogeneous nuclear ribonucleoprotein A1 in human T lymphocytes. The roles of cytoplasmic location, transcription, and phosphorylation.

Authors:  B J Hamilton; C M Burns; R C Nichols; W F Rigby
Journal:  J Biol Chem       Date:  1997-11-07       Impact factor: 5.157

9.  The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals.

Authors:  D E Eberhart; H E Malter; Y Feng; S T Warren
Journal:  Hum Mol Genet       Date:  1996-08       Impact factor: 6.150

10.  A mouse cytoplasmic exoribonuclease (mXRN1p) with preference for G4 tetraplex substrates.

Authors:  V I Bashkirov; H Scherthan; J A Solinger; J M Buerstedde; W D Heyer
Journal:  J Cell Biol       Date:  1997-02-24       Impact factor: 10.539

View more
  185 in total

1.  In sickness and in health: the importance of translational regulation.

Authors:  P R Reynolds
Journal:  Arch Dis Child       Date:  2002-05       Impact factor: 3.791

Review 2.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

3.  RNA structure analysis assisted by capillary electrophoresis.

Authors:  Krzysztof Sobczak; Wlodzimierz J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2002-11-15       Impact factor: 16.971

4.  Protein phosphatase 2A (PP2A)-specific ubiquitin ligase MID1 is a sequence-dependent regulator of translation efficiency controlling 3-phosphoinositide-dependent protein kinase-1 (PDPK-1).

Authors:  Beatriz Aranda-Orgillés; Désirée Rutschow; Raphael Zeller; Antonios I Karagiannidis; Andrea Köhler; Changwei Chen; Timothy Wilson; Sven Krause; Stefan Roepcke; David Lilley; Rainer Schneider; Susann Schweiger
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

5.  The RNA binding domain of Jerky consists of tandemly arranged helix-turn-helix/homeodomain-like motifs and binds specific sets of mRNAs.

Authors:  Wencheng Liu; Jeremy Seto; Etienne Sibille; Miklos Toth
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

6.  Translational repression of the disintegrin and metalloprotease ADAM10 by a stable G-quadruplex secondary structure in its 5'-untranslated region.

Authors:  Sven Lammich; Frits Kamp; Judith Wagner; Brigitte Nuscher; Sonja Zilow; Ann-Katrin Ludwig; Michael Willem; Christian Haass
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

7.  Signatures of RNA binding proteins globally coupled to effective microRNA target sites.

Authors:  Anders Jacobsen; Jiayu Wen; Debora S Marks; Anders Krogh
Journal:  Genome Res       Date:  2010-05-27       Impact factor: 9.043

Review 8.  Potential therapeutic interventions for fragile X syndrome.

Authors:  Josien Levenga; Femke M S de Vrij; Ben A Oostra; Rob Willemsen
Journal:  Trends Mol Med       Date:  2010-09-21       Impact factor: 11.951

Review 9.  FMR1: a gene with three faces.

Authors:  Ben A Oostra; Rob Willemsen
Journal:  Biochim Biophys Acta       Date:  2009-02-21

10.  A study of the ultrastructure of fragile-X-related proteins.

Authors:  Ljiljana Sjekloća; Petr V Konarev; John Eccleston; Ian A Taylor; Dmitri I Svergun; Annalisa Pastore
Journal:  Biochem J       Date:  2009-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.